Liu Z - Search Results

1

Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer.

Huang D, Zhang F, Tao H, Zhang S, Ma J, Wang J, Liu Z, Cui P, Chen S, Huang Z, Wu Z, Zhao L, Hu Y. Huang D, et al. Among authors: liu z. Target Oncol. 2020 Feb;15(1):93-100. doi: 10.1007/s11523-020-00703-3. Target Oncol. 2020. PMID: 32052340

2

Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.

Fang P, Hu JH, Cheng ZG, Liu ZF, Wang JL, Jiao SC. Fang P, et al. PLoS One. 2012;7(12):e49717. doi: 10.1371/journal.pone.0049717. Epub 2012 Dec 19. PLoS One. 2012. PMID: 23284624 Free PMC article. Review.

3

[Clinical characteristics and prognostic factors of malignancy-associated hypercalcemia in squamous cell carcinoma].

Zhang SJ, Hu Y, Jiao SC, Liu ZF, Tao HT. Zhang SJ, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Dec;34(6):585-9. doi: 10.3881/j.issn.1000-503X.2012.06.009. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012. PMID: 23286403 Chinese.

4

Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.

Zhang SJ, Hu Y, Qian HL, Jiao SC, Liu ZF, Tao HT, Han L. Zhang SJ, et al. Asian Pac J Cancer Prev. 2013;14(6):3937-40. doi: 10.7314/apjcp.2013.14.6.3937. Asian Pac J Cancer Prev. 2013. PMID: 23886210 Free article.

5

Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia.

Zhang SJ, Hu Y, Cao J, Qian HL, Jiao SC, Liu ZF, Tao HT, Han L. Zhang SJ, et al. Asian Pac J Cancer Prev. 2014 Jan;14(11):6715-9. doi: 10.7314/apjcp.2013.14.11.6715. Asian Pac J Cancer Prev. 2014. PMID: 24377594 Free article.

6

A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer.

Liu Z, Wei Z, Hu Y, Gao F, Hao L, Fang P, Sun S, Li J, Jiao S. Liu Z, et al. Med Oncol. 2015 Aug;32(8):216. doi: 10.1007/s12032-015-0660-5. Epub 2015 Jul 14. Med Oncol. 2015. PMID: 26168982 Clinical Trial.

7

Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.

Zhang Y, Zhao Y, Sun S, Liu Z, Zhang Y, Jiao S. Zhang Y, et al. Among authors: liu z. Tumour Biol. 2016 Aug;37(8):10155-60. doi: 10.1007/s13277-015-4662-x. Epub 2016 Jan 29. Tumour Biol. 2016. PMID: 26831656

8

Efficacy and safety of apatinib as second-line therapy for advanced gastric cancer: a single-center observational study.

Zhang Y, Gou M, Han C, Li J, Wang L, Qiao Q, Hu Y, Bai L, Liu Z. Zhang Y, et al. Among authors: liu z. Anticancer Drugs. 2018 Feb;29(2):184-189. doi: 10.1097/CAD.0000000000000582. Anticancer Drugs. 2018. PMID: 29215372

9

Risk factors for pneumonitis in patients treated with anti-programmed death-1 therapy: A case-control study.

Cui P, Liu Z, Wang G, Ma J, Qian Y, Zhang F, Han C, Long Y, Li Y, Zheng X, Sun D, Zhang J, Cai S, Jiao S, Hu Y. Cui P, et al. Among authors: liu z. Cancer Med. 2018 Aug;7(8):4115-4120. doi: 10.1002/cam4.1579. Epub 2018 May 23. Cancer Med. 2018. PMID: 29797416 Free PMC article.

10

Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients.

Liu Z, Wu L, Cao J, Yang Z, Zhou C, Cao L, Wu H, Shen H, Jin M, Zhang Y, Mao X, Xiang J, Ma K, Li B, Zhang T, Hu Y. Liu Z, et al. Onco Targets Ther. 2018 Oct 23;11:7323-7331. doi: 10.2147/OTT.S173391. eCollection 2018. Onco Targets Ther. 2018. PMID: 30425522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,572 results

Search Page

Filters